Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DrugLog® revealed theft of morphine

DrugLog® made it possible for Akademiska Barnsjukhuset in Uppsala to quickly discover that morphine had been stolen from the department of emergency pediatric care. infusion bags containing morphine had apparently been emptied of their contents and replaced with some other form of liquid.Pharmacolog's service team was contacted by Akademiska barnsjukhuset (Academic Childrens Hospital) in Uppsala and asked to check a number of measurements of a then unknown substance to compare against the database of drugs that the Pharmacolog has built up. Upon comparison and more careful examination, it

Cantargia reports high response rates with CAN04 combination therapy in NSCLC and presents next development steps

Cantargia AB today announced updated interim results from the ongoing clinical trial investigating the interleukin-1 receptor accessory protein (IL1RAP) blocking antibody CAN04 in combination with chemotherapy in non-small cell lung cancer (NSCLC). Tumor burden decreased in all 9 evaluable patients and in 6 of these patients, the decrease is large enough to be defined as a response. One patient treated for more than one year has an ongoing complete response and the other five have partial responses. The side effects are those expected from chemotherapy or CAN04. Neutropenia is more frequent

Custom Electric Manufacturing to merge into Kanthal as of January 1, 2021

Custom Electric Manufacturing was acquired by Sweden-based Kanthal in 2018 and will now go to market under the Kanthal brand. The transition will be effective as of January 1, 2021Custom Electric Manufacturing (CEM) will as of January 1, 2021 be fully integrated into Kanthal. According to Jon Hartmayer, Sales Area Manager NAFTA at Kanthal, going to market under the same brand will come with benefits for their customers: “CEM customers will get access to the complete portfolio of Kanthal products and services which means that they will get more done with one supplier. For Kanthal customers

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 53 - 23 SEPTEMBER 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, Motortramp A/S continuously sells shares pro rata and the market is to be informed accordingly – see the attached file. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451Anne-Louise Dam-Rasmussen, Head of Communications, tel.: +45 3273 0624

Announcement from the extra general meeting in ExpreS2ion Biotech Holding

The extra general meeting in ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") was held today on 23 September 2020 and the following resolutions were passed by the meeting.Amendments of the Company's articles of association The extra general meeting resolved, in accordance with the board of directors' proposal, to amend the Company's articles of association regarding, e.g., the limits for the share capital to a minimum of SEK 3,000,000 and a maximum of SEK 12,000,000 and the limits for the number of shares to a minimum of 27,250,000 and a maximum of 109,000,000. It was

Ahlstrom-Munksjö invests into new coating machine for formaldehyde free coating

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE, September 23, 2020 at 12:00 noon EEST Ahlstrom-Munksjö invests in a more sustainable coating machine in Billingsfors, Sweden, to enable formaldehyde free balancing and finish foils for furniture, as well as building and construction industries. The new machine is expected to be fully commissioned in the fourth quarter of 2021. In addition to enabling formaldehyde free coating, the new coating machine will also reduce CO\2\ emissions by an estimate of 20%, further strengthening Ahlstrom-Munksjö’s position as a supplier of sustainable fiber-based

Safe working methods needed to protect against Legionella

The Finnish Food Authority and the Finnish Institute for Health and Welfare (THL) found Legionella bacteria in a variety of growing media, compost and digestate samples. Illness caused by Legionella can be prevented by raising awareness of the Legionella risk and advising consumers and manufacturers on safe working methods.The Finnish Food Authority and THL investigated the prevalence of Legionella bacteria especially in fertilising products whose raw materials are subject to an increased Legionella risk due to their origin or treatment. Samples were taken, for example, from bagged potting

Vestas secures 46 MW order of 60 percent PTC qualifying turbine components in USA

News release from Vestas-American Wind TechnologyPortland, 23 September 2020 Vestas has received a 46 MW order of 4 MW platform turbine components that qualify for the 60 percent PTC value from an undisclosed customer. These components will enable future wind energy projects that complete construction by the end of 2024.  The PTC terms set in the PATH act, passed by Congress in 2015, made the wind industry the first energy industry to agree to permanent tax reform and have resulted in billions of dollars in wind energy investment in the U.S., including expansions in domestic

Shawbrook Bank Names New Commercial Director of its Consumer Division

· Amrita Kohli takes up the position following almost five years with Shawbrook · Delivered and launched the Bank’s initial personal loans proposition · Supported the growth of its Partner Finance team · Instrumental in securing key strategic partnerships with the likes of RAC and TescoLONDON: 23rd September 2020 Shawbrook Bank today (Wednesday, September 23rd) announced it has appointed a new Commercial Director for its Consumer division. Amrita Kohli takes up the position having played a significant role in Consumer’s foundational success and growth in recent years. She

Momentum Group acquires SKF’s Swedish spindle service operations

In order to further strengthen Momentum Group’s market position in service and maintenance for Swedish industry, the subsidiary Rörick Elektriska Verkstad AB (“Rörick”) has today signed an agreement to acquire SKF’s spindle service operations in Sweden. The acquired operations generate annual revenue of approximately MSEK 10 with favourable profitability. The acquisition will be conducted as a conveyance of assets and liabilities. The acquired service operations provide testing and maintenance of machine tool spindles, which are the heart of industrial machine tools. The existing unit at

Senzime communicates strategic and financial goals

Press release: Uppsala, September 23, 2020. Senzime AB (publ) today announces the company’s strategic and financial goals for 2023.   Senzime develops and markets digital patient monitoring systems to prevent complications during and after anesthesia. Senzime's TetraGraph system is currently CE marked, FDA cleared, and market approved, in additional countries such as Japan, South Korea and Australia. Since its launch in 2019, Senzime has delivered approximately 600 systems to hospitals worldwide. Despite limited access to hospitals during the COVID-19 pandemic, Senzime has had

This year's award-winner Baek Heena in upcoming film release

As part of the digital edition of the Gothenburg Book Fair Sep 24-27 in Sweden we present the premiere of a film about this year's laureate, the Korean picture book maker Baek Heena. Viewers will also have the chance to see the 2018 award-winner Jacqueline Woodson talking about her latest novel Red at the Bone, live from New York. Baek Heena, the 2020 ALMA laureateFriday 25 September at 14.30–14.45. Track: Extra inserted On March 31, 2020, the Astrid Lindgren Memorial Award struck like a bolt of lightning in the life of the South Korean picture book artist Baek Heena, as she put it

Influenza or COVID-19? Reliable diagnosis in 75 minutes with new multiplex assay from Abacus Diagnostica

Abacus Diagnostica is a small Finnish company developing and manufacturing assays and devices for rapid molecular diagnostics. Since the beginning of COVID-19 outbreak the company has worked decisively on the development of SARS-CoV-2 diagnostics. In July 2020, their SARS-CoV-2 assay for the GenomEra CDX system received the CE IVD approval for the European market. The results from the PCR-based COVID-19 test are available within 75 minutes. Because of the ease and rapidity of the system, many hospitals are using the assay for urgent samples such as testing the hospital personnel. -

Ingka Investments announces minority investment in Mover Systems

Ingka Investments, the investment arm of Ingka Group, owner and operator of 381 IKEA stores in 30 countries, announced that they will make a minority investment in Mover Systems, a Danish transportation and technology provider. The minority stake will support Mover in delivering effective logistical services for customers in other countries where Ingka Group operates.The evolving online shopping habits call for scalable and sustainable delivery models. IKEA wants to become more accessible, affordable and sustainable and Mover can provide services that make last-mile customer deliveries just

Read original

Wärtsilä to divest its JOVYATLAS business

Wärtsilä Corporation, Press release, 23 September 2020 at 10:00 AM EESTThe technology group Wärtsilä announces the divestment of 100% of the shares in Wärtsilä JOVYATLAS GmbH to Jacob Waitz Industrie GmbH, a German based industry holding. Wärtsilä JOVYATLAS has been manufacturing UPS systems, rectifiers, power inverters, frequency transformers and resistors with related services for many industries already for seven decades. The company became part of Wärtsilä as a result of the acquisition of L-3 Communications MSI in 2015. The company is located in Jemgum in Germany, and currently has

Getinge is announcing a voluntary recall of the Servo-i ventilator system’s nebulizer connector

Getinge is announcing a voluntary medical device recall for the Servo-i ventilator system due to a potentially shorter than specified nebulizer connector. This issue does not affect the functionality of the Servo-i ventilator system. To date, there have been no adverse events reported resulting in serious illness or injuries related to the mentioned component. Getinge has reported to relevant authorities according to applicable regulations and the cost for the recall is not material.Getinge has identified that 997 units have been manufactured that potentially could be affected by a shorter

Tikkurila Oyj – Managers’ Transactions

Tikkurila Oyj, Managers’ Transactions, 23 September 2020 at 10.00 a.m. (EET) Tikkurila Oyj – Managers’ Transactions With reference to the EU Market Abuse Regulation, Tikkurila Oyj has received a notification from Oras Invest Oy of a transaction made on 22 September 2020. Detailed information about the transaction is given below. Tikkurila Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Oras Invest Oy Position: Closely associated person (X) Legal person (1): Person Discharging

NORDEN raises expectations for the full-year result

ANNOUNCEMENT NO. 52 - 23 SEPTEMBER 2020 Due to a very strong performance in the Dry Operator business unit, NORDEN raises its expectations for the full-year 2020 Adjusted Result to USD 70-110 million (approximately DKK 445-700 million), up from USD 40-80 million.“Dry Operator is capitalising on having proactively chartered period vessels in the last quarter combined with efficient regional positioning of these vessels during the third quarter. This has enabled the business unit to enter into contracts with significantly better margins than previously expected”, says Jan Rindbo, CEO,

Company Announcement No. 87, 2020 – Addendum to Nordea Kredits final terms

The following security code has been added to the final terms of fixed rate callable covered mortgage bonds (SDRO): Callable fixed-rate annuity bond with option for interest-only period of 1-30 years ISIN code                Nom                 Name                       Opening          Closing           Maturity       Currency                                 interestrate/                                      date                 date                 date                               MaturityDK0002049006 1.0%

Magnolia Bostad AB (publ) reschedules the expiry date for priority allocation of new bonds in connection with partial tender offer of certain outstanding bonds

Magnolia Bostad AB (publ) (“Magnolia” or the “Issuer”) reschedules the expiry date for priority allocation of new bonds in connection with the tender offer (the “Tender Offer”) in respect of the Issuer’s outstanding SEK 600,000,000 senior unsecured bonds 2016/2021 (the “Existing Bonds”) from 12.00 CEST on 24 September 2020 to 16.00 CEST on 23 September 2020.As previously announced in a press release dated 17 September 2020, Magnolia is offering holders of the Existing Bonds to tender their Bonds for purchase by the Issuer for cash. In connection with the Tender Offer, the Issuer has also

New patents approved for ColdZyme in Japan and Russia

The Japanese Patent Office announced that it had granted Enzymatica’s patent (6718375) for the cod enzyme which is one of the key components in Enzymatica’s ColdZyme® cold spray. The patent includes use of the cod enzyme for treatment and prevention of microbial infections in individuals with immunodeficiency. The patent is valid until 2035. In addition, the Patent Office of the Russian Federation approved a patent in which cod enzymes (trypsin and chymotrypsin) are covered in combination with antibiotics for treatment of streptococcal biofilm in the upper and lower respiratory tract. The

SynAct Pharma Initiates Phase II Study with AP1189 for the Treatment of ARDS in COVID-19 Patients

SynAct Pharma AB ("SynAct Pharma") today announced the initiation of a Phase II clinical study to evaluate the safety and efficacy of the company’s lead candidate drug AP1189 in adults diagnosed with COVID-19 and with early signs of Acute Respiratory Distress Syndrome (ARDS). The patients will be enrolled at medical centers in Brazil and in a collaboration between SynAct Pharma, Queen Mary University, London, UK, and Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, to explore resolution therapy as a novel option for the treatment of hyperinflammation associated with COVID-19. The

There are no items matching the current filter
There are no more items matching the current filter
Back to top